Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2014 2
2015 3
2016 1
2017 1
2018 1
2019 3
2020 1
2021 6
2022 2
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
Broadbent DM, Wang A, Cheyne CP, James M, Lathe J, Stratton IM, Roberts J, Moitt T, Vora JP, Gabbay M, García-Fiñana M, Harding SP; ISDR Study Group. Broadbent DM, et al. Among authors: cheyne cp. Diabetologia. 2021 Jan;64(1):56-69. doi: 10.1007/s00125-020-05313-2. Epub 2020 Nov 4. Diabetologia. 2021. PMID: 33146763 Free PMC article. Clinical Trial.
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate.
Bromley RL, Calderbank R, Cheyne CP, Rooney C, Trayner P, Clayton-Smith J, García-Fiñana M, Irwin B, Morrow JI, Shallcross R, Baker GA; UK Epilepsy and Pregnancy Register. Bromley RL, et al. Among authors: cheyne cp. Neurology. 2016 Nov 1;87(18):1943-1953. doi: 10.1212/WNL.0000000000003157. Epub 2016 Aug 31. Neurology. 2016. PMID: 27581218
Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.
Eleuteri A, Fisher AC, Broadbent DM, García-Fiñana M, Cheyne CP, Wang A, Stratton IM, Gabbay M, Seddon D, Harding SP; Individualised Screening for Diabetic Retinopathy (ISDR) Study Group. Eleuteri A, et al. Among authors: cheyne cp. Diabetologia. 2017 Nov;60(11):2174-2182. doi: 10.1007/s00125-017-4386-0. Epub 2017 Aug 24. Diabetologia. 2017. PMID: 28840258 Free PMC article.
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
Pattni K, Hungerford D, Adams S, Buchan I, Cheyne CP, García-Fiñana M, Hall I, Hughes DM, Overton CE, Zhang X, Sharkey KJ. Pattni K, et al. Among authors: cheyne cp. BMC Infect Dis. 2022 Mar 20;22(1):270. doi: 10.1186/s12879-022-07239-z. BMC Infect Dis. 2022. PMID: 35307024 Free PMC article.
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
García-Fiñana M, Hughes DM, Cheyne CP, Broadbent DM, Wang A, Komárek A, Stratton IM, Mobayen-Rahni M, Alshukri A, Vora JP, Harding SP. García-Fiñana M, et al. Among authors: cheyne cp. Diabetes Obes Metab. 2019 Mar;21(3):560-568. doi: 10.1111/dom.13552. Epub 2018 Oct 30. Diabetes Obes Metab. 2019. PMID: 30284381 Free PMC article.
21 results